Vitamin Shoppe (VSI) Rating Increased to Buy at ValuEngine
Vitamin Shoppe (NYSE:VSI) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Thursday.
A number of other analysts have also issued reports on VSI. Zacks Investment Research lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Tuesday, November 7th. Morgan Stanley decreased their price objective on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 9th. Finally, Barclays decreased their price objective on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 9th. Four research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $4.95.
Shares of Vitamin Shoppe (VSI) opened at $4.00 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.32 and a current ratio of 2.25. Vitamin Shoppe has a one year low of $2.95 and a one year high of $22.70. The stock has a market capitalization of $95.91, a price-to-earnings ratio of -0.39 and a beta of 0.64.
In other Vitamin Shoppe news, major shareholder Shah Capital Management bought 300,000 shares of the firm’s stock in a transaction on Monday, February 5th. The shares were acquired at an average cost of $3.83 per share, for a total transaction of $1,149,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, major shareholder Vintage Capital Management Llc bought 133,804 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The stock was acquired at an average price of $4.28 per share, for a total transaction of $572,681.12. The disclosure for this purchase can be found here. Insiders acquired a total of 1,000,639 shares of company stock worth $4,387,647 over the last 90 days. Corporate insiders own 1.07% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Macquarie Group Ltd. bought a new position in Vitamin Shoppe in the 3rd quarter worth about $101,000. Lazard Asset Management LLC bought a new position in Vitamin Shoppe in the 4th quarter worth about $115,000. Crossmark Global Holdings Inc. increased its stake in Vitamin Shoppe by 122.8% in the 4th quarter. Crossmark Global Holdings Inc. now owns 31,320 shares of the specialty retailer’s stock worth $138,000 after acquiring an additional 17,260 shares during the last quarter. UBS Asset Management Americas Inc. increased its stake in Vitamin Shoppe by 17,041.4% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock worth $140,000 after acquiring an additional 11,929 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd increased its stake in Vitamin Shoppe by 72.7% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock worth $207,000 after acquiring an additional 7,478 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Vitamin Shoppe (VSI) Rating Increased to Buy at ValuEngine” was reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.dailypolitical.com/2018/03/03/vitamin-shoppe-vsi-rating-increased-to-buy-at-valuengine.html.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.